Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000899140-21-000770
Filing Date
2021-12-21
Accepted
2021-12-21 17:13:43
Documents
2
Group Members
CUBIST SYSTEMATIC STRATEGIES, LLCPOINT72 CAPITAL ADVISORS, INC.POINT72 HONG KONG LTDSTEVEN A. COHEN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G a122121a.htm SC 13G 62543
2 JOINT FILING AGREEMENT a122121b.htm EX-99.1 3039
  Complete submission text file 0000899140-21-000770.txt   67268
Mailing Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902
Business Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902 203-890-2000
Point72 Asset Management, L.P. (Filed by) CIK: 0001603466 (see all company filings)

EIN.: 465064661 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Subject) CIK: 0001604464 (see all company filings)

EIN.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88393 | Film No.: 211510200
SIC: 2836 Biological Products, (No Diagnostic Substances)